Considering the rumor of approval sent the stock above 0.40, it seems reasonable to conclude that the risk of rejection is not fully priced in.
At the same time, NWBO sits at a $375 million market cap, 50% of Iovance, generating $50 million in revenue per quarter. So on the basis of multiples of sales, NWBO is currently priced in at a level where execution is expected.
Market Data 
Markets 
AI
